Sold by: Kriv AI
Kriv AI delivers pharma / life-sciences-specialized Claude Code enablement for engineering teams at pharma, biotech, CROs, CMO/CDMOs, medical device, and diagnostic companies. Three tiers: half-day executive briefing ($8K), 2-day fundamentals ($15K), 5-day full enablement ($25K) + optional $10K Per-Team Deep-Dive. Pharma-Premium variant $10K/$18K/$30K available per deal where GxP scope is heavier. Curriculum covers 21 CFR Part 11 code patterns, ALCOA+, GxP SDLC, FDA CSA (Sept 2022), FDA PCCP (Dec 2024) for SaMD, EU Annex 11, ICH E6(R3), CDISC SDTM / ADaM / CDASH, MedDRA / WHODrug, GAMP 5 Second Edition. Claude on Amazon Bedrock in customer-controlled VPC with data residency and no training on customer inputs. Capstone: IQ/OQ/PQ validation evidence package from existing codebase. AWS Select + Databricks + Anthropic CPN member. Partner, not an Anthropic-authorized reseller.
Overview
Pharma and life-sciences engineering teams are being asked to ship AI-assisted code into clinical, manufacturing, pharmacovigilance, and regulatory-submission systems — all directly under FDA, EMA, MHRA, and PMDA scrutiny. Until now, no pharma-specialized Claude Code training existed on AWS Marketplace.
The regulatory surface has expanded sharply: FDA Computer Software Assurance (CSA, Sept 2022) moved industry from CSV to risk-based CSA; FDA PCCP for SaMD (Dec 2024); 2025 draft guidance on AI/ML in drug development; ICH E6(R3) GCP finalized 2025; EU Annex 11 / 15 + GAMP 5 Second Edition set the bar. FDA BIMO, MHRA, EMA, PMDA inspections keep ALCOA+ + Part 11 at the top of every Form 483 and Warning Letter — which makes Copilot / Codeium rollouts almost universally blocked in QA + CSV review.
Every AI coding training on AWS Marketplace today is industry-agnostic — none cover Part 11 code patterns, ALCOA+ review, CSA risk-based test generation, GAMP 5 categorization, CDISC SDTM/ADaM mapping, MedDRA/WHODrug coding, EDC integration (Medidata, Veeva Vault, Oracle Clinical One), or SaMD/PCCP patterns. Deloitte + Accenture Life Sciences run $75K–$250K+ bundled with advisory; ISPE GAMP + Veeva/Medidata certs cover platforms or compliance but not Claude Code. Kriv's E1 (healthcare), N18 (banking/FS), and N19 (insurance) prove the template; N20 completes the regulated-vertical family. N9 (Part 11 Compliance) + N12 (Clinical Trial Analytics + Part 11 Audit Trail) anchor Kriv's Part 11 credibility.
5-day curriculum. Day 1 — Foundations + secure setup: Claude on Bedrock in customer VPC; Opus 4.6 (validation-critical + MRM/traceability) / Sonnet 4.6 (1M context) / Haiku 4.5; IDE integrations; policy mapped to Part 11 + GxP SDLC + EU Annex 11 + SOC 2; validated vs non-validated isolation; CloudTrail logging. Day 2 — Core patterns: monorepo prompts; RAG for regulated reference data (SOPs, protocols, MedDRA, WHODrug, validation artifacts); multi-file refactors; Claude-authored tests; PR review with PHI/GxP tagging + ALCOA+ alignment. Day 3 — Pharma workflows: Part 11 code (audit trail via S3 Object Lock + CloudTrail; e-signature via Cognito + KMS; §11.300 controls); CDISC SDTM/ADaM/CDASH mapping; MedDRA + WHODrug coding microservice; Bedrock AE/SAE narrative drafting with mandatory human review; signal detection (EB05/PRR); protocol-deviation detection; enrollment-forecasting ML on SageMaker; EDC integration (Medidata, Veeva Vault, Oracle Clinical One); eCTD prep code; CSA risk-based test generation; IQ/OQ/PQ automation; validation evidence from code; MES/LIMS/CAPA; SaMD/PCCP patterns; GAMP 5 Cat 3/4/5. Day 4 — Security + compliance: §11.10 + §11.10(e) + §11.200; ALCOA+; CSA transition; EU Annex 11; ICH E6(R3); ICH Q9 QRM; HIPAA + GDPR Article 9; OWASP Top 10; SBOM for SaMD. Day 5 — Production rollout + ROI: phased rollout; productivity dashboard; Governance Committee charter aligned with Customer Quality; validation evidence automation; FDA BIMO readiness; capstone (IQ/OQ/PQ from existing codebase); 30-day office hours.
Hands-on labs (anonymized synthetic data): secure Bedrock + CSA audit logging; CDISC SDTM extractor; Bedrock AE narrative drafting with human-review gating; MedDRA/WHODrug coding microservice; protocol-deviation ML; EDC scaffolds; CSA risk-based test generator; IQ/OQ/PQ automation; SBOM for SaMD; capstone validation evidence package.
Three tiers. Executive Briefing — half-day $8K (up to 15 execs). Engineering Fundamentals — 2-day $15K (up to 20 engineers; Days 1–2 + labs). Full Enablement — 5-day $25K (Days 1–5 + capstone + 30-day office hours). Optional Per-Team Deep-Dive $10K (1-day for one squad of up to 10 — clinical ops/EDC; PV/Argus/ArisGlobal; manufacturing IT/MES/LIMS/CAPA; eCTD; SaMD/PCCP; diagnostic device). Pharma-Premium variant $10K/$18K/$30K per deal where GxP scope is heavier (private-offer quote, Pallavi discretion + Abhinav sign-off).
Important disclosures. Kriv is a member of the Anthropic Claude Partner Network (approved April 9, 2026) — partner, not an Anthropic-authorized reseller. Claude + API procured directly by Customer. No Anthropic / AWS / FDA / EMA / MHRA / PMDA / ISPE / vendor / regulator / accreditor certifications (Kriv completion certificates only); not CLE-/CPE-/CE-accredited. Kriv is NOT a CRO, NOT a 21 CFR-regulated entity; conducts no clinical trials, GMP manufacturing, or pharmacovigilance. No "21 CFR Part 11 certification" exists under FDA regulation. No legal / regulatory / clinical / GxP / compliance advice; represents Customer before no regulator; authors no FDA submissions. No guarantee of productivity uplift, Form 483 / Warning Letter avoidance, or inspection outcomes. Bedrock / Claude-generated AE/SAE narratives + validation artifacts + regulatory drafting are DRAFT only — qualified QA / PV / RA human review mandatory before any filing. Anthropic API + Bedrock + travel separate.
Highlights
- First pharma / life-sciences Claude Code training on AWS Marketplace — 21 CFR Part 11 + ALCOA+ + FDA CSA (Sept 2022) + FDA PCCP for SaMD (Dec 2024) + ICH E6(R3) + EU Annex 11 + GAMP 5 Second Edition aligned. Claude on Amazon Bedrock in customer-controlled VPC with data residency, no training on customer inputs, and environment isolation for validated vs non-validated + GxP-data vs non-GxP-data. Every prompt-to-code interaction logged via AWS CloudTrail.
- Veeva Vault / Medidata Rave / Oracle Clinical One integration patterns + CDISC SDTM / ADaM / CDASH + MedDRA / WHODrug coding microservices + GAMP 5 Category 3/4/5 + SaMD / PCCP code patterns + MES / LIMS / CAPA for manufacturing IT. Hands-on labs: CDISC SDTM extractor, Bedrock AE narrative drafting with mandatory human review, CSA risk-based test generator, IQ/OQ/PQ automation, SBOM for SaMD. Capstone: generate validation evidence package from an existing codebase.
- AWS Select + Databricks + Anthropic Claude Partner Network member (April 9, 2026; partner, not an Anthropic-authorized reseller). Three tiers $8K/$15K/$25K + $10K Per-Team Deep-Dive; Pharma-Premium $10K/$18K/$30K per deal for heavier GxP scope (Pallavi discretion + Abhinav sign-off; private-offer quote). Built for large pharma, mid-pharma, emerging biotech, CROs, CMO/CDMOs, medical device (including SaMD), diagnostics. Completes the E1 / N18 / N19 / N20 regulated-vertical training family.
Details
Sold by
Delivery method
Deployed on AWS
New
Introducing multi-product solutions
You can now purchase comprehensive solutions tailored to use cases and industries.
Pricing
Custom pricing options
Pricing is based on your specific requirements and eligibility. To get a custom quote for your needs, request a private offer.
Legal
Content disclaimer
Vendors are responsible for their product descriptions and other product content. AWS does not warrant that vendors' product descriptions or other product content are accurate, complete, reliable, current, or error-free.
Resources
Support
Vendor support
Primary contact. info@kriv.ai · +1-732-433-5564 · https://kriv.ai/support
Response SLA. First response within 2 US business days (Mon–Fri 9 am – 6 pm ET, ex-US federal holidays). Active cohorts: Lead Instructor within 4 business hours weekdays. FDA Form 483 / Warning Letter remediation or pre-BLA/NDA/MAA filing timelines compress to same business day.
Onboarding SLA. First customer contact within 2 US business days of buyer inquiry / private-offer acceptance. Classes kick off within 2–4 weeks of SOW (CISO + TPRM + QA + Validation Committee approval extends timing); 5–10 business days when driven by FDA remediation urgency.
Escalation. (1) Lead Instructor (named in SOW) → (2) Training Practice Director (info@kriv.ai ) → (3) CEO Abhinav Dangri (info@kriv.ai ).
Communication. Dedicated Microsoft Teams channel; daily standup during class delivery; 30-day post-class office hours (Full Enablement). Customer sponsor touchpoints: pre-class kickoff, mid-class checkpoint, post-class readout.
Handoff. Course materials + lab repos + capstone templates in secure file share; MRM / validation evidence templates as Word + Excel; FDA BIMO inspection readiness mini-guide as PDF; executive summary report within 5 business days of class end.
Out of scope. No Anthropic / AWS / FDA / EMA / MHRA / PMDA / ISPE / vendor / regulator / accreditor certifications (Kriv completion certificates only); not CLE-/CPE-/CE-accredited. Kriv is not a CRO and not a 21 CFR-regulated entity; conducts no clinical trials, GMP manufacturing, or pharmacovigilance. No legal / regulatory / clinical / GxP / compliance advice. Kriv represents Customer before no regulator; signs no FDA submissions.
AWS + Anthropic-side billing. Anthropic API + AWS Bedrock consumption billed directly; travel + on-site pass-through (remote is default).
Holiday coverage. Closed on US federal holidays; schedule adjusted at SOW execution.